LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | PF431396 | 1.11 | uM | LJP5 | 72 | hr | 1657 | 2395 | 5505 | 0.4350 | 0.1916 |
| BT-20 | PF477736 | 1.11 | uM | LJP5 | 72 | hr | 1657 | 5220 | 5505 | 0.9482 | 0.9259 |
| BT-20 | PF562271 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 3445 | 5505 | 0.6257 | 0.4645 |
| BT-20 | PHA-665752 | 1.11 | uM | LJP5 | 72 | hr | 1657 | 5697 | 5505 | 1.0348 | 1.0498 |
| BT-20 | PHA-793887 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 1984 | 5505 | 0.3605 | 0.0850 |
| BT-20 | PI103 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 1749 | 5505 | 0.3177 | 0.0237 |
| BT-20 | PLX-4720 | 1.11 | uM | LJP5 | 72 | hr | 1657 | 5517 | 5505 | 1.0021 | 1.0029 |
| BT-20 | QL-X-138 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 3161 | 5505 | 0.5742 | 0.3908 |
| BT-20 | QL-XII-47 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 1728 | 5505 | 0.3139 | 0.0183 |
| BT-20 | Radicicol | 1.11 | uM | LJP5 | 72 | hr | 1657 | 1892 | 5505 | 0.3437 | 0.0609 |
| BT-20 | Radicicol | 1.11 | uM | LJP6 | 72 | hr | 1657 | 1936 | 5505 | 0.3516 | 0.0723 |
| BT-20 | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 4763 | 5505 | 0.8652 | 0.8072 |
| BT-20 | Ruxolitinib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 5047 | 5505 | 0.9168 | 0.8810 |
| BT-20 | XL147 | 1.11 | uM | LJP5 | 72 | hr | 1657 | 5265 | 5505 | 0.9563 | 0.9375 |
| BT-20 | Saracatinib | 1.11 | uM | LJP6 | 72 | hr | 1657 | 4346 | 5505 | 0.7894 | 0.6986 |
| BT-20 | Selumetinib | 1.11 | uM | LJP6 | 72 | hr | 1657 | 5734 | 5505 | 1.0415 | 1.0593 |
| BT-20 | Sirolimus | 1.11 | uM | LJP6 | 72 | hr | 1657 | 3685 | 5505 | 0.6694 | 0.5269 |
| BT-20 | Sorafenib | 1.11 | uM | LJP6 | 72 | hr | 1657 | 4723 | 5505 | 0.8580 | 0.7968 |
| BT-20 | SU11274 | 1.11 | uM | LJP5 | 72 | hr | 1657 | 5287 | 5505 | 0.9604 | 0.9434 |
| BT-20 | Fedratinib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 4774 | 5505 | 0.8672 | 0.8099 |
| BT-20 | TGX221 | 1.11 | uM | LJP5 | 72 | hr | 1657 | 5449 | 5505 | 0.9897 | 0.9853 |
| BT-20 | Torin1 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 1451 | 5505 | 0.2636 | -0.0537 |
| BT-20 | Torin2 | 1.11 | uM | LJP5 | 72 | hr | 1657 | 1311 | 5505 | 0.2382 | -0.0899 |
| BT-20 | Tozasertib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 1732 | 5505 | 0.3146 | 0.0193 |
| BT-20 | Trametinib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 4292 | 5505 | 0.7796 | 0.6846 |